What's new

[PIO] 21 September: World Alzheimer's Day

30181.png





As the population ages, the incidence of dementia increases, with the result that the incidence of moderate to severe dementia is about 5% of the general population for people over 65, and 20%-40% for people over 85 years of age.

In addition, people with dementia make up 15%-20% of outpatients in outpatient clinics and 50% of people in chronic care facilities.

Alzheimer's dementia is the most common form of dementia and increases in prevalence with age.

Currently over 55 million people worldwide are living with dementia and by 2050 it is expected to reach 152.million, with approximately 10 million new cases of dementia occurring each year.

Dementia is the seventh leading cause of death and one of the leading causes of disability and dependency among older people.

Dementia is the seventh leading cause of death and one of the leading causes of disability and dependency among older people.

In 1907, Alois Alzheimer first described the disease, later named after him, in which the person shows progressive ablation of cognitive functions.

To clinically diagnose Alzheimer's dementia, a progressive ablation of cognitive functions without apparent onset is taken into account and includes specific neuropathological and neurochemical features.

Early-onset Alzheimer's dementia may occur in people younger than 65 years of age and usually has a rapid progression, whereas the late-onset form occurs in people older than 65 years and progresses more slowly.

Although the cause of Alzheimer's dementia remains unknown, researchers have made significant progress in understanding the molecular basis of the amyloid deposits that are a hallmark of the neuropathology of this disorder.

The severity and course of dementia can be influenced by psychosocial factors. Anxiety and depression may exacerbate and escalate the syndromes. The general therapeutic approach to people with dementia is primarily to provide supportive care, both for patients and their families, followed by medication for specific syndromes.

From a pharmaceutical point of view, cholinesterase inhibitors are used to treat mild to moderate dementia. Memantine protects neurons from excess glutamate, which can be neurotoxic. The therapist may also prescribe medication to treat other symptoms that may be present, such as insomnia, depression, delusions and hallucinations, always taking into account any side effects of these drugs. Exercise improves cognition in healthy adults and there is evidence that it may also be beneficial in dementia, particularly in the early stages.

Patients often benefit from psychoeducation, during which the clinician explains the nature and course of the disease. They also benefit from support, in grieving the loss of function, in accepting their disability and in issues relating to their self-esteem.

The areas of functioning that are not affected should be strengthened and they should be helped to find ways of coping with the areas that are affected e.g.

At the same time, interventions for family members of patients with dementia are very helpful. Caregivers struggle with feelings of guilt, grief, anger and exhaustion as they watch a family member gradually become disorganized.

Therapists can help family members understand the complex mix of emotions they are experiencing and offer support and acceptance to express these feelings. Therapists also need to be aware of the tendency of carers to blame themselves or others for the illness and need to appreciate the role that the person with dementia plays in the lives of family members.

Dementia has physical, psychological, social and economic implications, not only for the people living with it but also for their carers, families and society in general.

Therefore, the Ministry of Health must contribute to the prevention and treatment of this condition, not only to improve the quality of life of the population living with dementia and their families, but also to manage more effectively the consequences it has on the individual, society and the state.

(AF)
Contents of this article including associated images are owned by PIO
Views & opinions expressed are those of the author and/or PIO

Source

 
Back
Top